Benjamin M. Parsons
Gundersen Health System(US)Community Health Systems - Lutheran Hospital(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lymphoma Diagnosis and Treatment, Radiomics and Machine Learning in Medical Imaging, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial(2018)2,498 cited
- → Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial(2020)247 cited
- → A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era(2011)158 cited
- → Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma(2015)112 cited
- → Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy(2024)109 cited
- → Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma